众安提高疫苗副作用保障授助金额至每日1,000元 撤名额限制
众安国际宣布提高「新冠疫苗副作用保障」的住院现金援助金额,并取消名额限制,新安排下,如ZA Fam会员在接种由香港政府认可的新型冠状病毒疫苗後14天内因副作用而入院治疗,每日可获现金援助金额将由800元提升至1,000元,受保障住院时间亦由10日增长至15日。一旦会员不幸因疫苗副作用而身故,计划会为其提供一笔过20万的身故恩恤金。另外,计划将取消名额限制,希望能让更多有需要的社群受惠。
「ZA 抗疫保障金」的有效期至6月30日,凡持有有效香港身份证的香港居民,无论是新加入或现有的ZA Fam会员,均可免费参加计划 。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.